Elizabeth Halvorsen

Senior Director, Translational Biology at Seres Therapeutics

Elizabeth Halvorsen has an extensive background in microbiology, with experience working at various prestigious institutions and companies. Elizabeth has held positions ranging from Scientist I to Director in companies like Seres Therapeutics and Cubist Pharmaceuticals. Elizabeth's research focuses on infection prevention systems against pathogens, utilizing innovative assays to evaluate efficacy and safety of technology. Elizabeth has also conducted research on the role of specific proteins in infection models, as well as characterizing protein-protein interactions. Elizabeth holds a Ph.D. in Microbiology from the University of Illinois Urbana-Champaign and a Bachelor of Science in Biotechnology from Rutgers University.

Location

Boston, United States

Links

Previous companies


Org chart


Teams

This person is not in any teams


Offices


Seres Therapeutics

5 followers

Seres Therapeutics is developing revolutionary microbiome-based therapeutics to treat serious diseases.


Industries

Employees

201-500

Links